Summit Trail Advisors LLC increased its stake in shares of Genpact Limited (NYSE:G – Free Report) by 50.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 30,832 shares of the business services provider’s stock after acquiring an additional 10,375 shares during the quarter. Summit Trail Advisors LLC’s holdings in Genpact were worth $1,324,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also bought and sold shares of the company. Sanctuary Advisors LLC purchased a new stake in shares of Genpact in the second quarter valued at about $335,000. Inspire Investing LLC raised its holdings in shares of Genpact by 242.0% in the third quarter. Inspire Investing LLC now owns 37,277 shares of the business services provider’s stock valued at $1,462,000 after purchasing an additional 26,376 shares during the last quarter. Creative Planning raised its holdings in shares of Genpact by 19.4% in the third quarter. Creative Planning now owns 30,590 shares of the business services provider’s stock valued at $1,199,000 after purchasing an additional 4,976 shares during the last quarter. Birch Capital Management LLC raised its holdings in shares of Genpact by 23.6% in the third quarter. Birch Capital Management LLC now owns 93,216 shares of the business services provider’s stock valued at $3,655,000 after purchasing an additional 17,827 shares during the last quarter. Finally, Aaron Wealth Advisors LLC purchased a new stake in shares of Genpact in the third quarter valued at about $270,000. 96.03% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several analysts have recently commented on G shares. Mizuho increased their target price on shares of Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a report on Monday. Robert W. Baird raised their price objective on shares of Genpact from $44.00 to $48.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Needham & Company LLC raised their price objective on shares of Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a report on Friday. TD Cowen upgraded shares of Genpact from a “hold” rating to a “buy” rating and raised their price objective for the stock from $45.00 to $60.00 in a report on Friday. Finally, Jefferies Financial Group upgraded shares of Genpact from a “hold” rating to a “buy” rating and raised their price objective for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. Six analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, Genpact has a consensus rating of “Hold” and an average price target of $48.44.
Insider Activity at Genpact
In related news, SVP Piyush Mehta sold 12,000 shares of Genpact stock in a transaction on Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the transaction, the senior vice president now directly owns 151,182 shares of the company’s stock, valued at $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Balkrishan Kalra sold 9,000 shares of Genpact stock in a transaction on Monday, November 25th. The stock was sold at an average price of $46.40, for a total transaction of $417,600.00. Following the completion of the transaction, the chief executive officer now directly owns 267,404 shares in the company, valued at approximately $12,407,545.60. The trade was a 3.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 35,058 shares of company stock valued at $1,558,675 over the last three months. 2.80% of the stock is owned by corporate insiders.
Genpact Price Performance
G stock opened at $54.37 on Tuesday. The firm has a 50 day moving average of $45.09 and a 200-day moving average of $41.41. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50. Genpact Limited has a 12 month low of $30.23 and a 12 month high of $56.76. The firm has a market capitalization of $9.59 billion, a P/E ratio of 19.14, a price-to-earnings-growth ratio of 1.63 and a beta of 1.20.
Genpact (NYSE:G – Get Free Report) last announced its earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share for the quarter, missing analysts’ consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.61%. As a group, sell-side analysts predict that Genpact Limited will post 3.08 earnings per share for the current fiscal year.
Genpact Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Tuesday, March 11th will be paid a $0.17 dividend. This is an increase from Genpact’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 1.25%. The ex-dividend date of this dividend is Tuesday, March 11th. Genpact’s dividend payout ratio (DPR) is currently 23.94%.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also
- Five stocks we like better than Genpact
- The Most Important Warren Buffett Stock for Investors: His Own
- Merck: 4 No-Brainer Reasons to Buy This Dip
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Investing In Automotive Stocks
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.